TCG Crossover Management LLC 13D and 13G filings for Viridian Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-09-29 06:02 am Unchanged |
2021-09-23 | 13G | Viridian Therapeutics, Inc. VRDN |
TCG Crossover Management LLC | 1,314,000 8.200% |
0 (Unchanged) |
Filing |
| 2021-09-24 1:59 pm Purchase |
2021-09-21 | 13G | Viridian Therapeutics, Inc. VRDN |
TCG Crossover Management LLC | 1,314,000 13.700% |
400,000 (+43.76%) |
Filing |
| 2021-09-10 06:03 am Purchase |
2021-09-01 | 13G | Viridian Therapeutics, Inc. VRDN |
TCG Crossover Management LLC | 914,000 9.500% |
914,000 (New Position) |
Filing |